Supply Chain & Warehousing

Scan4Safety: What Lies Beyond the Barcode?

How patient-level traceability connects safety, reliable information and NHS investment decisions

Introduction

Few technologies are as familiar as the barcode. It appears on everything from groceries to complex medical devices, and scanning one is hardly a remarkable event. In healthcare, however, the information attached to that simple act can be far more consequential. A product can be linked to a patient, a procedure and a location; the same record can also support inventory control, recalls and a clearer account of what was used in delivering care.

That is the attraction of Scan4Safety. The initiative began with six NHS demonstrator trusts in 2016, using common identification standards to improve safety and operational efficiency. It has since developed into a wider conversation about the quality of information travelling between clinical activity, purchasing and supply chains.1 The significant question for NHS leaders is no longer whether a barcode can be scanned. It is what the organisation can reliably do with the information afterwards.

From useful stock data to patient-level assurance

In many industries, knowing which product is on which shelf is sufficient to manage an order. In a hospital, that may be only the beginning. A medical device can be received, stored, moved to a clinical department and ultimately used for a specific patient. Those stages matter for different reasons, and they do not always involve the same people, systems or budgets.

Scan4Safety uses internationally recognised GS1 identifiers for products, people and locations. Such standards offer a consistent way to identify what is being handled and where it is used. Their commercial significance lies…

Continue reading, free

Enter your email and we will send a 6-digit code to open the rest of this briefing.

Confirm your email to read briefings in full. No password or account needed. You’ll also receive a digest of new releases. Unsubscribe at any time; we never sell or share your information. Privacy notice

This briefing reflects the author's analysis and understanding of the market, based on professional experience and information available at the time of publication. It is provided for information and discussion and is not legal, financial, investment or other professional advice. Full disclaimer.

About the author

Ajay Channana is a senior procurement and commercial practitioner with more than two decades of senior commercial leadership experience across public and private sector organisations. He established Ipso Facto Consulting Limited in 2016.

Need deeper intelligence?

Bespoke commercial intelligence on markets, spend categories and sectors, from public or private perspectives.

Receive new CPO Insights briefings

Receive the commercial developments, deals and procurement signals worth watching. Enter your email and we will send a 6-digit code to confirm it is yours.

Confirm your email to read briefings in full. No password or account needed. You’ll also receive a digest of new releases. Unsubscribe at any time; we never sell or share your information. Privacy notice